"The UK Hib Vaccine Experience"

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

 

------------------------------------------------------------

 

June 14, 2002

 

INTERNATIONAL IMMUNIZATION NEWS

 

"The UK Hib Vaccine Experience"

Archives of Disease in Childhood Online (adc.bmjjournals.com)

(06/01/02) Vol. 86, No. 6, P. 396; Heath, P.T.; McVernon, J.

 

The United Kingdom's use of a vaccine against Haemophilus influenzae type b (Hib) is a valuable example of the benefit of such a vaccine in children younger than five years.  Hib conjugate vaccines were introduced in the United Kingdom in 1992, and since that time, cases of Hib have become extremely rare. The vaccine program includes an accelerated schedule, no required booster doses, and a catch-up period at the beginning of the program for those children who missed the start of the schedule. The Hib vaccination plan is a collaboration between doctors, microbiologists, and public health authorities, providing the opportunity for participants to study the disease and its near-eradication thoroughly.  The success of the vaccine program underlines the vaccine's effectiveness and the benefits of herd immunity, and it also allows experts to monitor the risks associated with the vaccine's failure.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.